TABLE 1.
Demographic characteristics, comorbidities, and postoperative complications among pediatric patients undergoing CM-I decompression surgery
Variable | No. of Pts | % |
---|---|---|
Total | 936 | 100 |
Age (yrs) | ||
0–5 | 228 | 24.4 |
6–12 | 332 | 35.5 |
13–18 | 376 | 40.2 |
Sex* | ||
Male | 448 | 49.6 |
Female | 456 | 50.4 |
Race* | ||
White | 537 | 62.1 |
Black | 73 | 8.4 |
Hispanic | 181 | 20.9 |
Other | 74 | 8.6 |
Payer status | ||
Private | 562 | 60.0 |
Medicaid | 299 | 31.9 |
Other | 75 | 8.0 |
Comorbidity | ||
Cardiovascular disease | 46 | 4.9 |
Congenital or genetic disease | 79 | 8.4 |
Gastrointestinal disease | —† | —† |
Hematol or immunol disease | 14 | 1.5 |
Hydrocephalus | 61 | 6.5 |
Metabolic disease | 11 | 1.2 |
Neoplastic disease | —† | —† |
Neuromuscular disease | 142 | 15.2 |
Renal disease | —† | —† |
Respiratory disease | 12 | 1.3 |
Scoliosis | 128 | 13.7 |
Syringomyelia | 273 | 29.2 |
Complications | ||
Surgical | 119 | 12.7 |
Medical | 24 | 2.6 |
Major‡ | 13 | 1.4 |
Hematol = hematological; immunol = immunological.
Sum of all groups is less than 936 due to the presence of missing data for sex (n = 32) and race (n = 71).
Suppressed because of cell size of 10 or less, due to restrictions defined by the Healthcare Cost and Utilization Project.
Includes myocardial infarction/heart failure, pulmonary embolism, and iatrogenic cerebrovascular infarction or hemorrhage.